Avaliação de metaloproteinases e de marcadores inflamatorios em pacientes com sindrome metabolica / Assesment of metaloproteinases and pro-inflammatory markers in patients with metabolic syndrome
AUTOR(ES)
Flavia Magazoni Gonçalves
DATA DE PUBLICAÇÃO
2009
RESUMO
The metabolic syndrome (MetS) denotes a clustering of cardiovascular and diabetes risk factors. The metalloproteinase (MMPs) are enzymes involved in maintaining the homeostasis of the extracellular matrix and an imbalance between their concentrations and their endogenous inhibitors (TIMPs) may play important role in the cardiovascular modifications associated with MetS. In addition, a chronic inflammatory state has been described in patients with MetS, thus leading to the development of atherosclerosis. We hypothesized that increased concentrations of pro-inflammatory mediators and imbalanced concentrations of matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs) may reflect the pathophysiology of MetS. To address this issue, we studied 25 healthy subjects and 25 MetS patients. The plasma levels of pro-MMP-2 and pro-MMP-9 were determined by gelatin zymography. The plasma concentrations of MMP-8, MMP-3, TIMP-1, TIMP-2, monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6), intercellular adhesion molecule (sICAM-1), and sP-selectin were measured by ELISA kits. The results revealed an increase in sP-selectin, sICAM-1, MCP-1, IL-6, pro-MMP-9, MMP-8, and TIMP-1 in MetS patients compared with healthy controls. In addition, no differences in pro-MMP-2, MMP-3, and TIMP-2 levels were found. These findings suggest that MMPs may have a role in the increased cardiovascular risk of MetS patients and pharmacological interventions targeting MMPs, especially MMP-9 and MMP-8 deserve further investigation in MetS patients
ASSUNTO(S)
metalloproteases metaloproteinase marcadores inflamatorios metabolic syndrome sindrome metabolica inflammatory markers
ACESSO AO ARTIGO
http://libdigi.unicamp.br/document/?code=000467299Documentos Relacionados
- The impact of metabolic syndrome on metabolic, pro-inflammatory and prothrombotic markers according to the presence of high blood pressure criterion
- Effects of natural aging and gender on pro-inflammatory markers
- Attenuated levels of pro-inflammatory markers in diabetic retinopathy patients undergoing treatment with antihyperglycemic and antihypertensive drugs
- Marcadores inflamatórios e infecciosos em pacientes com síndrome metabólica
- Study of some inflammatory markers and metabolic syndrome in overweight adolescents and in those metabolic obese normal weight